|
Q3 FY2020
As of May 31, 2020
|
Q2 FY2020
As of Feb 29, 2020
|
Q1 FY2020
As of Nov 30, 2019
|
Q4 FY2019
As of Aug 31, 2019
|
Q3 FY2019
As of May 31, 2019
|
Q2 FY2019
As of Feb 28, 2019
|
Q1 FY2019
As of Nov 30, 2018
|
Q4 FY2018
As of Aug 31, 2018
|
Q3 FY2018
As of May 31, 2018
|
Q2 FY2018
As of Feb 28, 2018
|
Q1 FY2018
As of Nov 30, 2017
|
Q4 FY2017
As of Aug 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Cash equivalents | ||||||||||||
| Deposit | ||||||||||||
| Prepaid expense | ||||||||||||
| Total Current Assets | ||||||||||||
| Total Assets | ||||||||||||
| Accrued expenses | ||||||||||||
| Accounts payable | ||||||||||||
| Loan from related party | ||||||||||||
| Total Current Liabilities | ||||||||||||
| TOTAL LIABILITIES | ||||||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 270,000,000 and 16,100,000 shares issued and outstanding as of May 31, 2020 and August 31, 2019, respectively | ||||||||||||
| Common stock, $0.0001 par value, 10,000 and 253,900,000 shares subscribed as of May 31, 2020 and August 31, 2019, respectively | ||||||||||||
| Common stock receivable | ||||||||||||
| Additional Paid In Capital | ||||||||||||
| Accumulated Deficit | ||||||||||||
| Total Stockholders' Equity | ||||||||||||
| Total Liabilities & Stockholders' Equity |
Loading...
